ClinicalTrials.gg
RecruitingNCT02852031NPC-QICUpdated Jun 19, 2025

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

An observational study in Hypoplastic Left Heart Syndrome (HLHS), sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 63 sites in 3 countries. Open to participants aged Up to 15 Months. Per ClinicalTrials.gov, last updated 2025-06-19.

Sponsored by Children's Hospital Medical Center, Cincinnati · Observational

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,000
Ages
Up to 15 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Hypoplastic Left Heart Syndrome with a site in United States — 6 open to participants now, 10 under way, 1 of them phase 3. Hypoplastic Left Heart Syndrome · United States.

Planned enrollment
Largest of 18
1,000 · median 96
Started
2016
with 1 other
Observational
18 of 44
3 open now
Registered
27th of 44
by date

Among the 44 studies in Hypoplastic Left Heart Syndrome with a site in United States, this one has the largest planned enrollment of the 18 observational ones that give a count, is one of 2 that started in 2016, is one of 18 observational ones, and was the 27th registered.

Hypoplastic Left Heart Syndrome

67 studies on the registry are indexed under Hypoplastic Left Heart Syndrome; 12 are open to participants now.

Browse Hypoplastic Left Heart Syndrome studies →

Open to participants now

6 of the 44 studies in Hypoplastic Left Heart Syndrome with a site in United States are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Hypoplastic Left Heart Syndrome studies recruiting now, 3 set no upper age limit and 6 stop at 75 or younger; 9 take children under 18; none take healthy volunteers.

This study: Up to 15 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Hypoplastic Left Heart Syndrome with a site in United States, or all of them as a file.
02

Study summary

The purpose of this initiative is to improve care and outcomes for infants with HLHS by expanding the NPC-QIC national registry to gather clinical care process, outcome, and developmental data on infants with HLHS between diagnosis and 12 months of age, by improving the use of standards into everyday practice across pediatric cardiology centers, and by engaging parents as partners in the process.

Read the detailed description

The purpose of this initiative is to improve care and outcomes for infants with HLHS by: 1) expanding the established NPC-QIC national registry to gather clinical care process, outcome, and developmental data on infants with HLHS between diagnosis and 12 months of age, 2) improving implementation of consensus standards, tested by teams, into everyday practice across pediatric cardiology centers, and 3) engaging parents as partners in improving care and outcomes.

03

Conditions studied

  • Hypoplastic Left Heart Syndrome (HLHS)
04

Who can participate

Ages eligible
Up to 15 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Infants diagnosed with HLHS

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fetuses or newborns diagnosed with HLHS or other univentricular condition
  • Intended to undergo Norwood procedure

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
15 Months
Patient registry
Yes

Groups and cohorts

  • Hypoplastic Left Heart Syndrome

    Infants diagnosed with Hypoplastic Left Heart Syndrome (HLHS)

    Other: Collaborative Learning Network

Interventions

  • OtherCollaborative Learning Network
06

What researchers measure

Primary outcomes

  1. Relationship between the implementation of changes in care delivery with changes in the process

    The purpose of this data sharing is to facilitate QI and research activities. As more information is gathered in this registry, the study team will determine the data analyses methods to determine if the knowledge gained led to changes in care delivery and/or to better patient outcomes.

    Time frame: 15 months

07

Study locations

59 of 63 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is no plan to make individual participant data available.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2016, a primary completion of May 2026 and a completion of May 2028. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 19, 2016
First posted
Aug 2, 2016
Start
May 2016
Primary completionEst.
May 2026
CompletionEst.
May 2028
Last update
Jun 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02852031
Responsible party
Sponsor
First posted
Aug 2, 2016
Start date
May 2016
Primary completion
May 2026 (estimated)
Completion
May 2028 (estimated)
Last update
Jun 19, 2025

Study contacts

Mark Timbers
Contact
mark.timbers@cchmc.org
Garick Hill, MD
principal investigator · Cininnati Children's Hospital Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion